Statement Of Cash Flows [Abstract]

BioArctic - Filing #702565

Concept	As at 2021-12-31	2021-01-01 to 2021-12-31	As at 2021-01-01	As at 2020-12-31	2020-01-01 to 2020-12-31	As at 2020-01-01
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Profit (loss)	—	139 723 SEK	—	—	85 012 SEK	—
Adjustments to reconcile profit (loss) [abstract]
Adjustments for decrease (increase) in other operating receivables	—	5 122 SEK	—	—	23 086 SEK	—
Adjustments for increase (decrease) in other operating payables	—	62,000 SEK	—	—	3 472 SEK	—
Other adjustments for non-cash items	—	5 230 SEK	—	—	19 991 SEK	—
Cash flows from (used in) operations	—	140 457 SEK	—	—	92 341 SEK	—
Interest paid, classified as operating activities	—	984,000 SEK	—	—	1 686 SEK	—
Interest received, classified as operating activities	—	388,000 SEK	—	—	7,000 SEK	—
Cash flows from (used in) investing activities [abstract]
Purchase of property, plant and equipment, classified as investing activities	—	4 386 SEK	—	—	12 473 SEK	—
Other inflows (outflows) of cash, classified as investing activities	—	27,000 SEK	—	—	51,000 SEK	—
Cash flows from (used in) investing activities	—	4 412 SEK	—	—	12 524 SEK	—
Cash flows from (used in) financing activities [abstract]
Payments of lease liabilities, classified as financing activities	—	7 389 SEK	—	—	6 598 SEK	—
Dividends paid, classified as financing activities	—	- SEK	—	—	- SEK	—
Cash flows from (used in) financing activities	—	7 389 SEK	—	—	6 598 SEK	—
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes	—	152 257 SEK	—	—	111 463 SEK	—
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents	—	723,000 SEK	—	—	1 367 SEK	—
Cash and cash equivalents	848 405 SEK	—	999 940 SEK	999 940 SEK	—	1 112 770 SEK